MCTA (Charming Medical) DeferredTaxAndRevenue: $3.72 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MCTA Charming Medical Ltd MCTA
29 GF Score
Price $29.36
! 6 Warning Signs
View Full Analysis

What is Charming Medical DeferredTaxAndRevenue?

Charming Medical MCTA -0.15% 29 DeferredTaxAndRevenue is $3.72 Mil as of Sep. 2025. GuruFocus rates MCTA with a GF Score™ of 29/100. The stock has 6 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Charming Medical's current deferred tax and revenue for the quarter that ended in Sep. 2025 was $3.72 Mil.

Charming Medical DeferredTaxAndRevenue Related Terms

Charming Medical DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Charming Medical's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charming Medical DeferredTaxAndRevenue Chart

Charming Medical Annual Data
Trend Mar23 Mar24 Mar25
DeferredTaxAndRevenue
5.60 4.50 3.46

Charming Medical Semi-Annual Data
Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
DeferredTaxAndRevenue Get a 7-Day Free Trial 0.00 4.50 4.18 3.46 3.72
MCTA
29GF Score
Charming Medical Ltd MCTA
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of $3.72 Mil mean?
Charming Medical (MCTA) has a DeferredTaxAndRevenue of $3.72 Mil as of Sep. 2025. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Charming Medical.
Is Charming Medical's DeferredTaxAndRevenue too high?
Charming Medical's current DeferredTaxAndRevenue is $3.72 Mil. Overall, Charming Medical has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Charming Medical's DeferredTaxAndRevenue compare to EHAB and CYH?
Charming Medical's DeferredTaxAndRevenue of $3.72 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Healthcare Providers & Services company?
A good DeferredTaxAndRevenue depends on the Healthcare Providers & Services industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Charming Medical. Charming Medical's current DeferredTaxAndRevenue is $3.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charming Medical stock overvalued right now?
Charming Medical (MCTA) has a current DeferredTaxAndRevenue of $3.72 Mil. The current DeferredTaxAndRevenue is $3.72 Mil. Charming Medical's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Charming Medical (MCTA), the current DeferredTaxAndRevenue is $3.72 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Charming Medical Business Description

Address 2-20 Paterson Street, Causeway Bay, Units 1803-1806, 18th Floor, Hang Lung Centre, Hong Kong, HKG
Charming Medical Ltd is a Hong Kong-based provider of Traditional Chinese Medicine (TCM)-inspired therapies and products. It offers a wide range of beauty, wellness, and postpartum services and products rooted and influenced by the principles and practices of TCM, such as the use of herbal ingredients, acupuncture techniques, Tuina massage, and dietary guidance. Its beauty, wellness, and postpartum services include but are not limited to womb-warming therapy, BTS (Beauty, Tailor-made, Slim) pelvic detox therapy, agarwood moxibustion therapy, TCM-inspired prenatal massage, and Indonesian traditional abdominal binding.
29GF Score

Get the complete analysis for MCTA

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.36
Price